Lexatumumab

Revision as of 16:52, 9 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Template:Drugbox-mab

WikiDoc Resources for Lexatumumab

Articles

Most recent articles on Lexatumumab

Most cited articles on Lexatumumab

Review articles on Lexatumumab

Articles on Lexatumumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Lexatumumab

Images of Lexatumumab

Photos of Lexatumumab

Podcasts & MP3s on Lexatumumab

Videos on Lexatumumab

Evidence Based Medicine

Cochrane Collaboration on Lexatumumab

Bandolier on Lexatumumab

TRIP on Lexatumumab

Clinical Trials

Ongoing Trials on Lexatumumab at Clinical Trials.gov

Trial results on Lexatumumab

Clinical Trials on Lexatumumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Lexatumumab

NICE Guidance on Lexatumumab

NHS PRODIGY Guidance

FDA on Lexatumumab

CDC on Lexatumumab

Books

Books on Lexatumumab

News

Lexatumumab in the news

Be alerted to news on Lexatumumab

News trends on Lexatumumab

Commentary

Blogs on Lexatumumab

Definitions

Definitions of Lexatumumab

Patient Resources / Community

Patient resources on Lexatumumab

Discussion groups on Lexatumumab

Patient Handouts on Lexatumumab

Directions to Hospitals Treating Lexatumumab

Risk calculators and risk factors for Lexatumumab

Healthcare Provider Resources

Symptoms of Lexatumumab

Causes & Risk Factors for Lexatumumab

Diagnostic studies for Lexatumumab

Treatment of Lexatumumab

Continuing Medical Education (CME)

CME Programs on Lexatumumab

International

Lexatumumab en Espanol

Lexatumumab en Francais

Business

Lexatumumab in the Marketplace

Patents on Lexatumumab

Experimental / Informatics

List of terms related to Lexatumumab


Overview

Lexatumumab (also known as ETR2-ST01) is a human monoclonal antibody used to treat cancer.

External links

Template:Humanmonoclonals

Template:WikiDoc Sources